Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of 1000 mg vs 500 mg Fast Release Aspirin
NCT03056703Phase 1Completed
- Sponsor
- Bayer
- Start
- Feb 2014
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of aspirin in pain (2 arms), sponsored by Bayer. Primary endpoints: Area under plasma concentration versus time curve from zero to infinity, Area under plasma concentration versus time curve from zero to last quantifiable concentration and 1 more. Started Feb 2014; status: completed.
02
Drugs
aspirin
03
Conditions
pain
Beyond the preview
Go deeper on NCT03056703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03056703.